The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
The Risk of Depression, Anxiety, and Suicidality in Patients With Psoriasis: A Population-Based Cohort Study
Open accessAbstract
OBJECTIVE: To determine the incidence of depression, anxiety, and suicidality in patients with psoriasis compared with the general population. DESIGN: A population-based cohort study using data collected as part of patient's electronic medical record from 1987 to 2002. SETTING: General Practice Research Database. PATIENTS: Analyses included 146 042 patients with mild psoriasis, 3956 patients with severe psoriasis, and 766 950 patients without psoriasis. Five controls without psoriasis were selected from the same practices and similar cohort entry dates as patients with psoriasis. MAIN OUTCOME MEASURE: Clinical diagnoses of depression, anxiety, and suicidality among patients. RESULTS: The adjusted hazard ratios (HRs) for receiving a diagnosis of depression, anxiety, and suicidality in patients with psoriasis compared with controls were 1.39 (95% confidence interval [CI], 1.37-1.41), 1.31 (95% CI, 1.29-1.34), and 1.44 (95% CI, 1.32-1.57), respectively. The adjusted HR of depression was higher in severe (HR, 1.72; 95% CI, 1.57-1.88) compared with mild psoriasis (HR, 1.38; 95% CI, 1.35-1.40). Younger patients with psoriasis had elevated HRs of outcomes compared with older patients with psoriasis. CONCLUSIONS: Patients with psoriasis have an increased risk of depression, anxiety, and suicidality. We estimate that in the United Kingdom, in excess of 10 400 diagnoses of depression, 7100 diagnoses of anxiety, and 350 diagnoses of suicidality are attributable to psoriasis annually. It is important for clinicians to evaluate patients with psoriasis for these conditions to improve outcomes. Future investigation should determine the mechanisms by which psoriasis is associated with psychiatric outcomes as well as approaches for prevention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pathogenesis and clinical features of psoriasis
Griffiths, C. E., & Barker, J. N. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61128-3 · Cited by 2,158
Risk of myocardial infarction in patients with psoriasis
Gelfand, J. M., Neimann, A. L., Shin, D. B., Wang, X., Margolis, D. J., & Troxel, A. B. (2006) · JAMA · doi:10.1001/jama.296.14.1735 · Cited by 1,899 · cited 2×
“excess cardiovascular risk and mortality in patients with more severe disease.(2-4) Pso-”
BackgroundMethodSelf-citationTyring, S., Gottlieb, A., Papp, K., Gordon, K., Leonardi, C., Wang, A., Lalla, D., Woolley, M., Jahreis, A., Zitnik, R., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(05)67763-x · Cited by 1,069 · cited 2×
“Recent data suggest thatpsychiatriccomorbiditymaynegativelyaffect response tocertainpsoriasis treatments (eg,photochemotherapy),(10) while other studies suggest that control of psoriasis is associated with improvements in psychological symptoms.(26) Future studies are necessary to determine the mechanisms by which pso…”
BackgroundPrevalence and Treatment of Psoriasis in the United Kingdom: A Population-Based Study
Gelfand, J. M., Weinstein, R., Porter, S. B., Neimann, A. L., Berlin, J. A., & Margolis, D. J. (2005) · Archives of Dermatology · doi:10.1001/archderm.141.12.1537 · Cited by 600
Self-citationEpidemiology of psoriatic arthritis in the population of the United States
Gelfand, J. M., Gladman, D. D., Mease, P. J., Smith, N., Margolis, D. J., Nijsten, T., Stern, R. S., Feldman, S. R., & Rolstad, T. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2005.03.046 · Cited by 596
Self-citationValidity of the General Practice Research Database
Jick, S. S., Kaye, J. A., Vasilakis‐Scaramozza, C., Rodríguez, L. A. G., Ruigómez, A., Meier, C. R., Schlienger, R. G., Black, C., & Jick, H. (2003) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.23.5.686.32205 · Cited by 584
The Risk of Mortality in Patients With Psoriasis: Results From a Population-Based Study
Gelfand, J. M., Troxel, A. B., Lewis, J. D., Kurd, S. K., Shin, D. B., Wang, X., Margolis, D. J., & Strom, B. L. (2007) · Archives of Dermatology · doi:10.1001/archderm.143.12.1493 · Cited by 533
Self-citationKurd, S. K., & Gelfand, J. M. (2009) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.09.022 · Cited by 519
Self-citationDeterminants of quality of life in patients with psoriasis: A study from the US population
Gelfand, J. M., Feldman, S. R., Stern, R. S., Thomas, J., Rolstad, T., & Margolis, D. J. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.04.014 · Cited by 367
Self-citationLewis, J. D., Bilker, W. B., Weinstein, R. B., & Strom, B. L. (2005) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1115 · Cited by 341
Cited by
The Bidirectional Relationship of Depression and Inflammation: Double Trouble
Beurel, E., Toups, M., & Nemeroff, C. B. (2020) · Neuron · doi:10.1016/j.neuron.2020.06.002 · Cited by 2,136
Psoriasis and comorbid diseases
Takeshita, J., Grewal, S., Langan, S. M., Mehta, N. N., Ogdie, A., Van Voorhees, A. S., & Gelfand, J. M. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.07.064 · Cited by 1,145
Self-citationDalgard, F. J., Gieler, U., Tomas-Aragones, L., Lien, L., Poot, F., Jemec, G. B. E., Misery, L., Szabo, C., Linder, D., Sampogna, F., et al. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.530 · Cited by 968
Elmets, C. A., Leonardi, C. L., Davis, D. M. R., Gelfand, J. M., Lichten, J., Mehta, N. N., Armstrong, A. W., Connor, C., Cordoro, K. M., Elewski, B. E., et al. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.11.058 · Cited by 503
Self-citationPsoriasis Prevalence in Adults in the United States
Armstrong, A. W., Mehta, M. D., Schupp, C. W., Gondo, G. C., Bell, S. J., & Griffiths, C. E. M. (2021) · JAMA Dermatology · doi:10.1001/jamadermatol.2021.2007 · Cited by 474
Abuabara, K., Azfar, R. S., Shin, D. B., Neimann, A. L., Troxel, A. B., & Gelfand, J. M. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.09941.x · Cited by 472
Self-citationPerera, G. K., Di Meglio, P., & Nestle, F. O. (2012) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011811-132448 · Cited by 462
Guidelines of care for the management of psoriasis and psoriatic arthritis
Menter, A., Korman, N. J., Elmets, C. A., Feldman, S. R., Gelfand, J. M., Gordon, K. B., Gottlieb, A., Koo, J. Y. M., Lebwohl, M., Leonardi, C. L., et al. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.11.055 · Cited by 460
Self-citationRaharja, A., Mahil, S. K., & Barker, J. N. (2021) · Clinical Medicine · doi:10.7861/clinmed.2021-0257 · Cited by 443
Dowlatshahi, E. A., Wakkee, M., Arends, L. R., & Nijsten, T. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.508 · Cited by 436
The role of IL-17 in CNS diseases
Waisman, A., Hauptmann, J., & Regen, T. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1402-7 · Cited by 340
Beyond a neurotransmitter: The role of serotonin in inflammation and immunity
Wu, H., Denna, T. H., Storkersen, J. N., & Gerriets, V. A. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2018.06.015 · Cited by 338
Samarasekera, E. J., Neilson, J. M., Warren, R. B., Parnham, J., & Smith, C. H. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.149 · Cited by 298
Beurel, E., & Lowell, J. A. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.08.001 · Cited by 187
Psychiatric adverse events during treatment with brodalumab: Analysis of psoriasis clinical trials
Lebwohl, M. G., Papp, K. A., Marangell, L. B., Koo, J., Blauvelt, A., Gooderham, M., Wu, J. J., Rastogi, S., Harris, S., Pillai, R., et al. (2018) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2017.08.024 · Cited by 179
Yue, T., Li, Q., Wang, R., Liu, Z., Guo, M., Bai, F., Zhang, Z., Wang, W., Cheng, Y., & Wang, H. (2020) · Dermatology · doi:10.1159/000498848 · Cited by 169
Kimball, A. B., Leonardi, C., Stahle, M., Gulliver, W., Chevrier, M., Fakharzadeh, S., Goyal, K., Calabro, S., Langholff, W., Menter, A., et al. (2014) · British Journal of Dermatology · doi:10.1111/bjd.13013 · Cited by 117
“2 10 Patients with psoriasis have an increased risk of depression and anxiety compared with the general population, 11 and lifestyle risk factors that may exacerbate psoriasis itself or complications of the disease, such as smoking and alcohol use, are highly prevalent in this patient population.”
BackgroundA pilot study examining mindfulness-based cognitive therapy in psoriasis
Fordham, B., Griffiths, C. E. M., & Bundy, C. (2015) · Psychology, Health & Medicine · doi:10.1080/13548506.2014.902483 · Cited by 116
Griffiths, C. E. M., Fava, M., Miller, A. H., Russell, J., Ball, S. G., Xu, W., Acharya, N., & Rapaport, M. H. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000479163 · Cited by 115
Martino, M., Rocchi, G., Escelsior, A., & Fornaro, M. (2012) · Current Neuropharmacology · doi:10.2174/157015912800604542 · Cited by 111
Rush, G., O’Donovan, A., Nagle, L., Conway, C., McCrohan, A., O’Farrelly, C., Lucey, J. V., & Malone, K. M. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.06.035 · Cited by 86
Psoriasis and Depression: The Role of Inflammation
González-Parra, S., & Daudén, E. (2019) · Actas Dermo-Sifiliográficas (English Edition) · doi:10.1016/j.adengl.2018.05.035 · Cited by 70
Maddock, A., & Blair, C. (2023) · Current Psychology · doi:10.1007/s12144-021-02082-y · Cited by 68
Distinct characteristics of hippocampal pathogenic th17 cells in a mouse model of depression
Beurel, E., Lowell, J. A., & Jope, R. S. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.04.012 · Cited by 65
Gałecka, M., Bliźniewska-Kowalska, K., Orzechowska, A., Szemraj, J., Maes, M., Berk, M., Su, K.-P., & Gałecki, P. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11020066 · Cited by 57
A Randomized Trial of Mindfulness-Based Cognitive Therapy with Psoriasis Patients
Maddock, A., Hevey, D., D’Alton, P., & Kirby, B. (2019) · Mindfulness · doi:10.1007/s12671-019-01242-3 · Cited by 39
Bloechliger, M., Ceschi, A., Rüegg, S., Kupferschmidt, H., Kraehenbuehl, S., Jick, S. S., Meier, C. R., & Bodmer, M. (2016) · Drug Safety · doi:10.1007/s40264-015-0363-z · Cited by 40
Sozzani, S., Abbracchio, M. P., Annese, V., Danese, S., De Pità, O., De Sarro, G., Maione, S., Olivieri, I., Parodi, A., & Sarzi-Puttini, P. (2014) · Autoimmunity · doi:10.3109/08916934.2014.897333 · Cited by 22
Florian, P., Flechsenhar, K. R., Bartnik, E., Ding‐Pfennigdorff, D., Herrmann, M., Bryce, P. J., & Nestle, F. O. (2020) · Experimental Dermatology · doi:10.1111/exd.13942 · Cited by 20
Maddock, A., Hevey, D., D’Alton, P., & Kirby, B. (2020) · Journal of Clinical Psychology in Medical Settings · doi:10.1007/s10880-019-09686-4 · Cited by 19
Discontinuation of antidepressant therapy among patients with major depressive disorder
Davé, S., Classi, P., Kim Le, T., Maguire, A., & Ball, S. (2012) · Open Journal of Psychiatry · doi:10.4236/ojpsych.2012.24038 · Cited by 14
“Containing approximately 11 million patients and 67 million patient years of data, the GPRD is a good resource for longitudinal epidemiological research, and has been widely used for studies on depression [11-14].”
Testing a Moderated Mediation Model of MBCT’s Effects for Psoriasis Patients
Maddock, A., Hevey, D., D’Alton, P., & Kirby, B. (2019) · Mindfulness · doi:10.1007/s12671-019-01249-w · Cited by 12
Eckardt, M., Stadtmueller, L., Zick, C., Kupfer, J., & Schut, C. (2024) · Acta Dermato-Venereologica · doi:10.2340/actadv.v104.18277 · Cited by 7
“Patients with psoriasis are more prone to depression and anxiety than the general population (3).”
Background
Metadata
- Authors
- OLIVIER, C., ROBERT, P. D., DAIHUNG, D., URBÀ, G., CATALIN, M. P., HYWEL, W., Kurd, S. K., Troxel, A. B., Crits-Christoph, P., & Gelfand, J. M.
- Venue
- Archives of Dermatology
- Publisher
- American Medical Association (AMA)
- Published
- 2010-08-01
- Volume
- 146
- Issue
- 8
- Pages
- 891-5
- ISSN
- 0003-987X (ISSN-L)
- OpenAlex
- W1987574038
- Cited by
- 642
- References
- 26
- FWCI
- 9.84
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.